Molecular Diagnostics Market size to exceed $10bn by 2023

1
Molecular Diagnostics Market size to exceed 10bn
by 2023Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Molecular Diagnostics Market

• North America, with U.S. molecular diagnostics
  market share taking over 88 revenue in 2015, is
  set to grow at 7.8 CAGR for the forecast
  timeframe.
• Global molecular diagnostics market size for
  infectious diseases estimates were USD 5.3
  billion in 2015, with over 8 CAGR growth
  expected by the industry.
• Germany, UK and Italy together were responsible
  for over 52 of Europe molecular diagnostics
  market revenue in 2015. Escalating population,
  government support in management of infections,
  and rising lifestyle changes of the people are
  other vital factors aiding growth.
• Developing countries including China, India and
  New Zealand will be primary growth drivers for
  the APAC molecular diagnostics industry. Recent
  outbreak of infectious diseases such as Ebola,
  swine flu, and MERS in some countries and unmet
  needs in accurate diagnostics will instigate
  growth.

3
Continued...

• PCR technology will continue to dominate the
  global molecular diagnostics market in terms of
  revenue, which was more than USD 2.4 billion in
  2015. PCR is the simplest and foremost procedure
  conducted prior to the commencement of any
  molecular diagnostic investigation involving
  nucleotides and genetic material, and remains
  most conventional and trusted gold standard
  technology for the amplification of DNA.
• With high entry barriers, new entrants have a
  tough time penetrating the industry, which is
  dominated by global multinationals. Strategic
  mergers and acquisitions is one of the major
  strategies adopted by the players to enter this
  market.
• Roche caters to over 25 of the global molecular
  diagnostics industry, with an extensive product
  portfolio especially catering to molecular
  diagnostic assay reagents, equipments and
  consumables, it was followed by Abott and
  Danaher.

4
North America molecular diagnostics market size,
by infectious diseases, 2014 - 2023 (USD Million)

5

Browse Full Market Research Report On Molecular
Diagnostics Market _at_ http//goo.gl/jdyKRg
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/434
6
360 Analysis

• Product Analysis
• Sexually Transmitted diseases (STD) dominated the
  overall molecular diagnostics market size in
  2015, by infectious diseases, with revenue close
  to USD 1 billion, followed by HIV. HIV and STD
  demonstrate maximum penetration due to increasing
  occurrence and ease of diagnosis. HPV disease
  market is expected to witness highest growth with
  9.8 CAGR. The market is predicted to expand if
  preventive care is not exercised in developing
  and under-developed nations.
• growth.
• Regional Analysis
• North America, led by U.S. molecular diagnostics
  market size, is forecast to exceed USD 4.2
  billion by 2023, remaining the largest regional
  industry. This market size can be attributed to
  the presence high technology adoption, improved
  healthcare infrastructure, high patient awareness
  levels, and high RD pertaining to drug discovery
  and development.
• Competitive Market Share
• Global molecular diagnostics market share was led
  by Roche Diagnostics, Abbott Laboratories, and
  Danaher Corporation, collectively grabbing a
  share of around 48 in 2015. The market is also
  marked by the presence of other active players
  such as Siemens Healthcare, BD, Qiagen, Bayer
  Healthcare, Novarits, and Dako among others

7
Stay In Touch Website www.gminsights.com Soci
al Media